New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study

• Váldodahkkit: Cristina Maccallini (Dahkki), Marialucia Gallorini (Dahkki), Francesca Sisto (Dahkki), Atilla Akdemir (Dahkki), Alessandra Ammazzalorso (Dahkki), Barbara De Filippis (Dahkki), Marialuigia Fantacuzzi (Dahkki), Letizia Giampietro (Dahkki), Simone Carradori (Dahkki), Amelia Cataldi (Dahkki), Rosa Amoroso (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Nonsteroidal aromatase inhibitors (NSAIs) are well-established drugs for the therapy of breast cancer. However, they display some serious side effects, and their efficacy can be compromised by the development of chemoresistance. Previously, we have reported different indazole-based carbamates and pi...